Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital

BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to be a significant health problem worldwide. The unprecedented surge of mucormycosis in patients with COVID-19 is a new emerging challenge. Although a few studies documenting high incidence of mucormycosis in COVID -19 patients have recently...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Abha, Rao, Nusumu Purnachandra, Patnaik, Uma, Malik, Virender, Tevatia, Manvir Singh, Thakur, Shivali, Jaydevan, Jijesh, Saxena, Pavitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313063/
https://www.ncbi.nlm.nih.gov/pubmed/34334896
http://dx.doi.org/10.1016/j.mjafi.2021.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313063/
https://www.ncbi.nlm.nih.gov/pubmed/34334896
http://dx.doi.org/10.1016/j.mjafi.2021.06.009

Ejemplares similares